UBS Group’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,354
| Closed | -$8K | – | 7513 |
|
|
2018
Q1 | $8K | Buy |
9,354
+9,346
| +116,825% | +$7.99K | ﹤0.01% | 6169 |
|
|
2017
Q4 | $0 | Sell |
8
-4,692
| -100% | – | ﹤0.01% | 7311 |
|
|
2017
Q3 | $17K | Buy |
4,700
+4,482
| +2,056% | +$16.2K | ﹤0.01% | 5687 |
|
|
2017
Q2 | $1K | Buy |
218
+158
| +263% | +$725 | ﹤0.01% | 6647 |
|
|
2017
Q1 | $1K | Sell |
60
-247
| -80% | -$4.12K | ﹤0.01% | 6636 |
|
|
2016
Q4 | $30K | Buy |
307
+72
| +31% | +$7.04K | ﹤0.01% | 5321 |
|
|
2016
Q3 | $23K | Sell |
235
-277
| -54% | -$27.1K | ﹤0.01% | 5320 |
|
|
2016
Q2 | $63K | Buy |
512
+412
| +412% | +$50.7K | ﹤0.01% | 4507 |
|
|
2016
Q1 | $13K | Buy |
+100
| New | +$13K | ﹤0.01% | 5681 |
|
|
2015
Q4 | – | Sell |
-137
| Closed | -$13K | – | 7344 |
|
|
2015
Q3 | $13K | Buy |
+137
| New | +$13K | ﹤0.01% | 5794 |
|
|
2015
Q2 | – | Sell |
-87
| Closed | -$15K | – | 7171 |
|
|
2015
Q1 | $15K | Buy |
+87
| New | +$15K | ﹤0.01% | 5640 |
|